Trials / Unknown
UnknownNCT05990673
Dose of Remi in Children
Determination of the 50% and 95% Effective Dose of Remimazolam for Intravenous Anesthesia Induction in Pediatric Patients
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- Sponsor
- Zhihong LU · Academic / Other
- Sex
- All
- Age
- 3 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
Remimazolam has demonstrated the potential as a valuable medication for procedural sedation and general anesthesia. However, the effective dosage of remimazolam in pediatric patients is still unknown.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Remimazolam | remimazolam is given intravenously |
Timeline
- Start date
- 2023-08-10
- Primary completion
- 2023-09-10
- Completion
- 2023-09-10
- First posted
- 2023-08-14
- Last updated
- 2023-08-14
Source: ClinicalTrials.gov record NCT05990673. Inclusion in this directory is not an endorsement.